Kuo comments that contract production of chips is merely a service activity and a source of income for the company-TGS's ultimate goal is in doing R & D work to identify gene sequences as targets for developing new drugs.
郭東源表示，生物晶片代工只是服務行業、公司生財的工具，公司終極目標還是研發，尋找藥物的標的（基因）。